European Commission names companies in EU pay-for-delay probe
This article was originally published in SRA
Executive Summary
The European Commission has fired warning shots at Lundbeck and Servier in its long-running probe into the possibility that pharmaceutical companies have engaged in anti-competitive business practices1,2. This is the first case that may lead to commission action against companies for "pay-for-delay" tactics to keep competing generic products off the market.